Efficacy and Safety of Kunxian Capsule in Treatment Patients With Early Ankylosing Spondylitis
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This is a prospective randomized controlled study to evaluated the efficacy and safety of
kunxian capsule in treating of patients with early ankylosing spondylitis (AS). The major
outcome index is proportion of patients achieving ASAS20 response at week12, and minor
outcome indexes include ASAS50 and ASAS70, BASDAI20,BASDAI50 and BASDAI70. The adverse events
at any time were recorded to evaluate the safety.